Clinical Trial Update: Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating chromium picolinate for improving insulin sensitivity in Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chromium Picolinate (chromium picolinate)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED